Advertisement
Advertisement
Trending on Urology Times
1
Lina Posada Calderon, MD, provides insights on germline BAP1–associated renal cell carcinoma
2
Targeting BCG resistance in high-risk NMIBC
3
Pearls & Perspectives: Navigating Evidence Gaps and Innovation in OAB Care, With Ariana Smith, MD
4
